Sales Of Business Components (Details) - USD ($)			1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 18, 2016	Feb. 03, 2016	Jan. 31, 2015	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture of business				$ 19,795,000
Hancock Jaffe Laboratories Inc [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Distribution agreement amount of payment	$ 3,400,000		$ 576,000			$ 1,700,000
Additional payments to affiliates				1,200,000	$ 1,200,000
Inventory	1,700,000
HeRO Graft Product Line [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Amount of consideration received from sale of product line		$ 18,500,000
Proceeds from divestiture of business				$ 17,800,000
Maximum duration of manufacting responsiblity per transition supply agreement		6 months
Pre-tax gain (loss) on sale business components		$ 8,800,000
HeRO Graft And ProCol Product Lines [Member] | Maximum [Member] | Revenue [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Concentration percentage					10.00%
HeRO Graft And ProCol Product Lines [Member] | Maximum [Member] | Assets, Total [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Concentration percentage					10.00%
ProCol [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture of business	2,000,000
Pre-tax gain (loss) on sale business components	845,000
Remaining prepayments	$ 1,700,000